An engineered carrier is part of the intervention. Evidence for a loaded material cannot be assumed to describe free peptide or another delivery system. Primary study
What was reported
Researchers adsorbed GHK–copper onto hydroxyapatite microspheres and incorporated them into a gel formulation. They reported sustained release over seven days and favorable inflammatory and oxidative-stress measurements in cell and animal experiments. Histological collagen deposition was also described. The report concerns preclinical material development, not a controlled cosmetic trial in people. Primary report
Our appraisal: release duration is not clinical duration of benefit
A release profile describes how material leaves a carrier under specified testing conditions. It does not directly measure how long a person benefits, how much intact compound reaches a target, or how frequently a clinical procedure would be needed. Those are separate questions requiring relevant data.
Carrier effects need to be distinguished from payload effects. The gel, microspheres, and surface interactions may influence local behavior independently of the peptide. Appropriate unloaded-carrier and free-compound comparisons help determine which part of the formulation contributes to a result.
Reduced inflammatory signals can support a material-development hypothesis without establishing the absence of adverse reactions. Long-term compatibility, persistence, migration, and delayed responses require their own assessment. Short-term laboratory compatibility should not be described as comprehensive human safety.
Collagen deposition is similarly contextual. Its location, organization, durability, and functional consequences matter more than a simple claim that staining increased.
The study is useful evidence about a specific experimental delivery material. It should not be transformed into instructions for injection, proof of facial rejuvenation, or a claim that adding GHK–copper makes any filler safe. The formulation remains distinct from ordinary topical or research-grade peptide preparations.
Frequently asked questions
Was a hydroxyapatite carrier used?
Yes.
Was GHK–copper loaded onto that carrier?
Yes.
Was release behavior measured?
Yes.
Is release duration the same as duration of clinical benefit?
No.
Was this a controlled human cosmetic trial?
No.
Does reduced inflammation establish complete safety?
No.
Are free peptide and loaded filler interchangeable?
No.